Redeye returns with a more in-depth take on Sedana Medical’s Q4 report. We leave our financial estimates for the coming years untouched but argue that the report further underpins our favorable stance on the company’s outlook.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/